Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 42 publications
Oncologist, Business Leader, and Investor Arie S. Belldegrun Discusses a Career in Innovative Medical Entrepreneurship: A Conversation with Ken Herrmann and Johannes Czernin.
Journal: Journal of nuclear medicine : official publication, Society of Nuclear Medicine
Published: October 30, 2024
Gain of Chromosome 5q Predicts a Favorable Prognosis in Localized Renal Cell Carcinoma.
Journal: Cancer investigation
Published: February 05, 2024
A Phase I, Open-label, Dose-escalation, and Cohort Expansion Study to Evaluate the Safety and Immune Response to Autologous Dendritic Cells Transduced With AdGMCA9 (DC-AdGMCAIX) in Patients With Metastatic Renal Cell Carcinoma.
Journal: Journal of immunotherapy (Hagerstown, Md. : 1997)
Published: September 14, 2020
Evaluation of the prognostic role of co-morbidities on disease outcome in renal cell carcinoma patients.
Journal: World journal of urology
Published: November 26, 2018
Melanoma-associated antigen-A and programmed death-ligand 1 expression are associated with advanced urothelial carcinoma.
Journal: Cancer immunology, immunotherapy : CII
Published: May 22, 2018
Receptor activator of NF-κB (RANK)-mediated induction of metastatic spread and association with poor prognosis in renal cell carcinoma.
Journal: Urologic oncology
Published: April 04, 2018
Utility of multiphasic multidetector computed tomography in discriminating between clear cell renal cell carcinomas with high and low carbonic anhydrase-IX expression.
Journal: Abdominal radiology (New York)
Published: March 10, 2018
Overall survival in patients with metastatic renal cell carcinoma and clinical N1 disease undergoing cytoreductive nephrectomy and lymph node dissection.
Journal: Urologic oncology
Published: June 27, 2017
Trends in usage of cytoreductive partial nephrectomy and effect on overall survival in patients with metastatic renal cell carcinoma.
Journal: Urologic oncology
Published: June 15, 2017
Adjuvant Therapy for High Risk Localized Kidney Cancer: Emerging Evidence and Future Clinical Trials.
Journal: The Journal of urology
Published: April 21, 2017
Last Updated: 09/26/2026